105339 people have viewed this drug in the last 60 days
Updated 2025-04-26
| Last Update | 2023-01-19 |
| Register Year | 2021 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | PEGCETACOPLAN |
| Trade Name | Empaveli 1080 mg per 20 ml |
| Strength Unit | mg/ml |
| Pharmaceutical Form | Solution for infusion |
| Administration Route | Subcutaneous use |
| Atc Code1 | L04AA |
| Atc Code2 | |
| Size | 20 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $18371.6 |
| Shelf Life | 24 Months |
| Marketing Company | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB |
| Marketing Country | Sweden |
| Manufacture Name | Cangene BioPharma Inc. (CBI) |
| Manufacture Country | United States |
| Secondry package manufacture | |
| Main Agent | Arabian Trade House |
| Secosnd Agent | |
| Third Agent | |
| Visits | 105339 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| Empaveli 1080 mg per 20 ml 8 vials | $146972.8 | 110730 visits | 2023-01-19 |
| Empaveli 1080 mg per 20 ml | $18371.6 | 105339 visits | 2023-01-19 |